Literature DB >> 17686573

Current concepts and controversies in the management of non-functioning giant pituitary macroadenomas.

Amit Agrawal1, Rafael Cincu, Atul Goel.   

Abstract

Despite their histologically benign nature, giant and 'invasive' pituitary tumors are one of the most complex neurosurgical challenges. In the present article, we discuss the current approaches to the management of giant pituitary tumors. Giant non-functioning pituitary tumors are usually confined inferiorly by the sellar dura, superiorly by the elevated diaphragma sellae, and laterally by an intact medial wall of the cavernous sinus. If the anatomical extensions of the tumor are understood and a radical tumor resection is achieved, the visual and long-term outcome can be extremely rewarding. The goals of surgery are to make a pathologic diagnosis and since the majority of these tumors are endocrinologically silent, the second goal should be to decompress the neural tissue. With the increasing experience and better understanding of anatomy of these tumors, trans-sphenoidal approaches have now replaced craniotomy for the excision of these tumors.

Entities:  

Mesh:

Year:  2007        PMID: 17686573     DOI: 10.1016/j.clineuro.2007.06.007

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  16 in total

1.  Short-term treatment with cabergoline can lead to tumor shrinkage in patients with nonfunctioning pituitary adenomas.

Authors:  Erica C Garcia; Luciana A Naves; Arthur O Silva; Lucas F de Castro; Luiz A Casulari; Monalisa F Azevedo
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

Review 2.  Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas.

Authors:  Ricardo J Komotar; Robert M Starke; Daniel M S Raper; Vijay K Anand; Theodore H Schwartz
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

3.  Pituitary adenomas in elderly patients: clinical and surgical outcome analysis in a large series.

Authors:  Alfio Spina; Marco Losa; Pietro Mortini
Journal:  Endocrine       Date:  2019-06-17       Impact factor: 3.633

Review 4.  Giant pituitary adenoma: histological types, clinical features and therapeutic approaches.

Authors:  Pedro Iglesias; Víctor Rodríguez Berrocal; Juan José Díez
Journal:  Endocrine       Date:  2018-06-16       Impact factor: 3.633

5.  Safety and efficacy of the direct endonasal transsphenoidal approach for challenging sellar tumors.

Authors:  Nader Sanai; Alfredo Quiñones-Hinojosa; Jared Narvid; Sandeep Kunwar
Journal:  J Neurooncol       Date:  2007-12-19       Impact factor: 4.130

6.  Visual field defects in 23 acromegalic patients.

Authors:  Emrah Kan; Elif Kilic Kan; Aysegul Atmaca; Hulusi Atmaca; Ramis Colak
Journal:  Int Ophthalmol       Date:  2013-02-09       Impact factor: 2.031

7.  Degrees of Diaphragma Sellae Descent during Transsphenoidal Pituitary Adenoma Resection: Predictive Factors and Effect on Outcome.

Authors:  Ahmed Abdelmaksoud; Peng Fu; Osamah Alwalid; Ahmed Elazab; Ahmed Zalloom; Wei Xiang; Xiao-Bing Jiang; Hong-Yang Zhao
Journal:  Curr Med Sci       Date:  2018-10-20

8.  Analysis of operative efficacy for giant pituitary adenoma.

Authors:  Shousen Wang; Shun'an Lin; Liangfeng Wei; Lin Zhao; Yinxing Huang
Journal:  BMC Surg       Date:  2014-08-28       Impact factor: 2.102

9.  The role of multimodal navigation in endoscopic endonasal surgery for giant pituitary adenomas.

Authors:  Chen Yang; Jiarui Zhang; Jianzhong Li; Nan Wu; Dong Jia
Journal:  Gland Surg       Date:  2019-12

10.  Nonfunctioning giant pituitary adenomas: Invasiveness and recurrence.

Authors:  José Alberto Landeiro; Elissa Oliveira Fonseca; Andrea Lima Cruz Monnerat; Giselle Fernandes Taboada; Gustavo Augusto Porto Sereno Cabral; Felippe Antunes
Journal:  Surg Neurol Int       Date:  2015-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.